DENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) P/B ratio
As of 5 November 2026, DENTSPLY SIRONA Inc. (XRAY) trades at a P/B ratio of 1.5×. Over the past ten years it has ranged from 1.2× (June 2016) to 3.9× (December 2015); the current reading is higher than 7% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.7× | (14.31%) |
| FY2024 | 2.0× | (13.44%) |
| FY2023 | 2.3× | 24.09% |
| FY2022 | 1.8× | (24.21%) |
| FY2021 | 2.4× | 4.85% |
| FY2020 | 2.3× | (6.15%) |
| FY2019 | 2.5× | 52.40% |
| FY2018 | 1.6× | (30.03%) |
| FY2017 | 2.3× | 47.77% |
| FY2016 | 1.6× | (56.81%) |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 1.3× | (16.88%) |
| Jun 2026 | 1.6× | (10.79%) |
| Mar 2026 | 1.8× | 3.36% |
| Dec 2025 | 1.7× | (0.70%) |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| AZTA Azenta, Inc. compare | 1.1× |
| XRAY DENTSPLY SIRONA Inc. | 1.5× |
| STVN Stevanato Group S.p.A. compare | 2.0× |
| STAA STAAR Surgical Company compare | 3.6× |
| LMAT LeMaitre Vascular, Inc. compare | 4.4× |
| ATRC AtriCure, Inc. compare | 5.6× |
| KMTS Kestra Medical Technologies, Ltd. compare | 7.4× |
| WRBY Warby Parker Inc. compare | 8.1× |
| PLSE Pulse Biosciences, Inc compare | 20.8× |
| Medical Instruments & Supplies industry median | 2.3× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement